MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment
Characterized by positive symptoms (such as changes in behavior or thoughts, including delusions and hallucinations), negative symptoms (such as apathy, anhedonia, and social withdrawal), and cognitive impairments, schizophrenia is a chronic, severe, and disabling mental disorder with late adolescence or early adulthood onset.Antipsychotics are the